H.C. Wainwright Reiterates Their Buy Rating on Synlogic Inc


In a report released yesterday, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Synlogic Inc (NASDAQ: SYBX), with a price target of $20. The company’s shares opened today at $9.54, close to its 52-week low of $8.73.

Selvaraju said:

“We reiterate our Buy rating and $20 12-month target on SYBX.”

According to TipRanks.com, Selvaraju is a 3-star analyst with an average return of 2.3% and a 40.1% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as IntelliPharmaCeutics International, Biospecifics Technologies Corp, and EyePoint Pharmaceuticals Inc.

Synlogic Inc has an analyst consensus of Moderate Buy, with a price target consensus of $17.50.

See today’s analyst top recommended stocks >>

The company has a one-year high of $23 and a one-year low of $8.73. Currently, Synlogic Inc has an average volume of 96.98K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Synlogic, Inc. is a clinical-stage biopharmaceutical company, which engages in drug discovery and development platform for synthetic biotic medicines. It focuses on metabolic diseases with the potential to be corrected following oral delivery of a living medicine to the gut.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts